logo

For the Inventor, By the Inventor

Perchtoldsdorf, Austria

Christiane Kofink

This inventor holds 12 USPTO granted patents and 5 published patent applications. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christiane Kofink. Retrieved from https://idiyas.com/inventor/christiane-kofink

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 100.0

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 33(Granted Patents)


Location History:

  • Vienna, AT (2013 - 2014)
  • Perchtoldsdorf, AT (2018 - 2024)

Company Filing History:

goldMedal12 out of 1,562 
 
Boehringer Ingelheim International Gmbh
 patents

Years Active: 2013-2025

Loading Chart...
12 patents (USPTO):Explore Patents
1. RE50594 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors (2025-09-23),
2. 12053473 - Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors (2024-08-06),
3. 11814380 - Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors (2023-11-14),
4. 10898487 - Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors (2021-01-26),
5. 10882866 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors (2021-01-05),
6. 10829487 - Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors (2020-11-10),
7. 10717742 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors (2020-07-21),
8. 10144739 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors (2018-12-04),
9. 10138251 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors (2018-11-27),
10. 8895581 - [object Object] (2014-11-25),
11. 8637549 - Pyridons as PDK1 inhibitors (2014-01-28),
12. 8575203 - Chemical compounds (2013-11-05),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an article about inventor Christiane Kofink's remarkable contributions to the fields of technology and sustainability.

Title: Christiane Kofink: Pioneering Innovation in Technology and Sustainability

Introduction:

Christiane Kofink, a visionary inventor based in Perchtoldsdorf, AT, is renowned for his passion for innovation and commitment to creating a better world through his inventions. With a total of 11 patents to his name, Kofink has made significant strides in advancing cutting-edge technologies aimed at improving sustainability.

Latest Patents:

Among his latest patents are groundbreaking inventions such as "Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors" and "Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors." These inventions demonstrate Kofink's expertise in developing compounds with therapeutic potential for treating oncological diseases.

Career Highlights:

Currently associated with Boehringer Ingelheim International GmbH, Kofink has established himself as a key figure in the company's research and development endeavors. His innovative approach to drug discovery has led to the successful filing of multiple patents, showcasing his dedication to advancing medical science.

Collaborations:

Throughout his career, Kofink has collaborated with talented individuals in the industry, including notable coworkers such as Juergen Ramharter and Tobias Wunberg. These collaborations have not only enhanced Kofink's innovative capabilities but have also fostered a culture of creativity and excellence within the workplace.

Conclusion:

In conclusion, Christiane Kofink's unwavering dedication to innovation and sustainability has positioned him as a prominent figure in the realm of technology and research. His pioneering inventions continue to inspire future generations of inventors and researchers, leaving an indelible mark on the landscape of medical science and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…